Fangsheng Pharmaceutical
6039989.460.00% ( 0.00 )
Fangsheng Pharmaceutical (603998)
Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical pr...
- Open
- 9.38
- High
- 9.50
- Low
- 9.33
- Prev. Close
- 9.46
- Volume
- 71.67K
- Turnover
- 67.55M
- Avg Price
- 9.42
- Bid/Ask Ratio
- 21.71%
- Amplitude
- 1.80%
- 52wk High
- 13.20
- Volume Ratio
- 0.58
- Turnover Ratio
- 1.63%
Fangsheng Pharmaceutical Analyst Rating
View MoreForecast & Rating
Jun 26, 2026Price forecast
¥16.6475.90%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Zhitong · Oct 23, 2025 at 07:45 AM
Fangsheng Pharmaceutical released its performance for the first three quarters, with a net profit attributable to the parent company of 268 million yuan, a year-on-year increase of 17.6%
- Zhitong · Oct 15, 2025 at 03:48 AM
Fangsheng Pharmaceutical: Clinical trial for Relugolix tablets approved
- Zhitong · Oct 9, 2025 at 03:20 AM
Fangsheng Pharmaceutical plans to acquire the marketing authorization for "Compound Acetate Dexamethasone Cream."
- Zhitong · Sep 23, 2025 at 04:43 AM
Fangsheng Pharmaceutical: The summary report of the Phase II clinical trial for Zhilong Tongluo tablets has been obtained
- Zhitong · Sep 4, 2025 at 03:29 AM
Fangsheng Pharmaceutical: Clinical trial for gynecological hemostatic and analgesic granules approved
- Zhitong · Aug 28, 2025 at 05:26 AM
Fangsheng Pharmaceutical: Net profit in the first half of 2025 increased by 23.67% year-on-year
